Key Programme Achievements (2011- Jun 2024)

212,101
number of adults and children currently receiving ART
1.7 Million+
number of notified cases of all forms of TB
2.1 Million+
number of confirmed malaria cases treated
25,118
number of MDR-TB cases that began second-line treatment
121.9 Million+
number of condoms distributed free of charge to KAP
71.4 Million+
needles and syringes distributed to people who inject drugs
20,557
number of PWID on opioid substitution therapy
26.9 million+
number of malaria tests performed (RDT and slides)

HIV Programme Achievements

2023

During 2023, in Myanmar, the political situation continued to bring up many challenges in the way programmes are implemented in the country. In these times of crisis, PR-UNOPS and its implementing partners worked hard to preserve the continuation of essential health services so that the interventions were not interrupted.

2022

In 2022, the COVID-19 pandemic continued to impact healthcare services, including for people living with and affected by HIV. Moreover, in Myanmar, the political situation continued to bring up many challenges in the way programmes are implemented in the country. In these times of crisis, PR-UNOPS and its implementing partners worked hard to preserve the continuation of essential health services while undertaking COVID-19 infection control measures so that the interventions were not interrupted.

2021

The cumulative results for 2021 are shown as a percentage of the annual target. The indicators on sex workers, men who have sex with men, and people who inject drugs reached, along with HIV counselling and testing and TB status assessed, are funded by GFATM only, whereas the others are funded by GFATM and other donors.

2020

The cumulative results for 2020 are shown as a percentage of the annual target. The indicators on sex workers, men who have sex with men, and people who inject drugs reached, along with HIV counselling and testing and TB status assessed, are funded by GFATM only, whereas the others are funded by GFATM and other donors.

2019

The cumulative results for 2019 are shown as a percentage of the annual target. The indicators on sex workers, men who have sex with men, and people who inject drugs reached, along with HIV counselling and testing and TB status assessed, are funded by GFATM only, whereas the others are funded by GFATM and other donors.

2018

The cumulative results for 2018 are shown as a percentage of the annual target. The indicators on sex workers, men who have sex with men, and people who inject drugs reached, along with HIV counselling and testing and TB status assessed, are funded by GFATM only, whereas the others are funded by GFATM and other donors.

2017

The cumulative results for Year 7 (NFM) are shown as a percentage of the annual target. The indicators on sex workers, men who have sex with men, and people who inject drugs reached, along with HIV counselling and testing and TB status assessed, are funded by GFATM only, whereas the others are funded by GFATM and other donors.

2016

The cumulative results for Year 6 (NFM) are shown as a percentage of the annual target. The indicators on sex workers, men who have sex with men, and people who inject drugs reached, along with HIV counselling and testing and TB status assessed, are funded by GFATM only, whereas the others are funded by GFATM and other donors.

There has been significant progress in implementation of the HIV grant, with 10 out of 16 reportable indicators either meeting or exceeding 100 per cent of the annual target by the end of 2016.

2015

The cumulative results for Year 5 (NFM) are shown as a percentage of the annual target. The indicators on sex workers, men who have sex with men, and people who inject drugs reached, along with HIV counselling and testing and TB status assessed, are funded by GFATM only, whereas the others are funded by GFATM and other donors.

There has been significant progress in implementation of the HIV grant, with 14 out of 15 reportable indicators either meeting or achieving more than 100 per cent of the annual target by the end of 2015.

2014

The cumulative results for 2014 are shown as a percentage of the annual target. Sex workers, MSM, PWID reached, HCT, and TB status assessed indicators are funded by GFATM only, while the others are funded by “GFATM and other donors”.

2013

The cumulative results for Year 1 (NFM) are shown as a percentage of the annual target. Sex workers, MSM and PWID reached indicators are funded by GFATM only, while the others are funded by “GFATM and other donors”.

2012

The cumulative results in each period during Year 2 are shown as a percentage of the annual target. Sex Workers, MSM and IDUs reached are funded by the Global Fund only, while the others are funded by "GFATM and other donors"

2011

The cumulative results in each period (P1-P4) are shown as a percentage of the annual target. Sex Workers, MSM and IDUs reached are funded by the Global Fund only, while the others are funded by "GFATM and other donors"

TB Programme Achievements

2023

In 2023, amidst the political instability in the country which brought up many challenges in the way programmes were implemented, PR-UNOPS and its implementing partners continued to maintain TB case finding, diagnosis and treatment services so that the interventions were ensured not to be interrupted.

2022

In 2022, PR-UNOPS worked closely with the public sector service providers and sub-recipients to maintain TB prevention, care, and treatment services while undertaking COVID-19 infection control measures so that the interventions were ensured not to be interrupted. 

During the year, 107,086 (77% of the annual target) TB patients were notified and enrolled in treatment. The treatment success rate was 87% (97% of the target). 

2021

The cumulative results for 2021 are shown as a percentage of the annual target. TB–HIV indicators (collaborative sites) and MDR-TB treatment indicators are funded by GFATM and other donors, while the others are funded by GFATM only.

2020

The cumulative results for 2020 are shown as a percentage of the annual target. TB–HIV indicator (collaborative sites) and MDR-TB treatment indicators are funded by GFATM and other donors, while the others are funded by GFATM only.

2019

The cumulative results for 2019 are shown as a percentage of the annual target. TB–HIV indicator (collaborative sites) and MDR-TB treatment indicators are funded by GFATM and other donors, while the others are funded by GFATM only.

2018

The cumulative results for 2018 are shown as a percentage of the annual target. TB–HIV indicator (collaborative sites) and MDR-TB treatment indicators are funded by GFATM and other donors, while the others are funded by GFATM only.

TB grant implementation has also shown progress, with 7 out of 18 reportable indicators either meeting or exceeding the annual targets by the end of 2018.

During the year, 133,909 (84% of the annual target) TB patients were notified and enrolled on treatment. The treatment success rate was 87 per cent.

2017

The cumulative results for Year 7 (NFM) are shown as a percentage of the annual target. TB–HIV indicator (collaborative sites) and MDR-TB treatment indicators are funded by GFATM and other donors, while the others are funded by GFATM only.

TB grant implementation has also shown progress, with 6 out of 14 reportable indicators either meeting or exceeding the annual targets by the end of 2017.

During the year, 130,414 (84% of the annual target) TB patients were notified and enrolled on treatment. The treatment success rate was 88 per cent.

2016

The cumulative results for Year 6 (NFM) are shown as a percentage of the annual target. TB–HIV indicator (collaborative sites) and MDR-TB treatment indicators are funded by GFATM and other donors, while the others are funded by GFATM only.

TB grant implementation has also shown progress, with five out of eight reportable indicators either meeting or exceeding the annual targets.

2015

The cumulative results for Year 5 (NFM) are shown as a percentage of the annual target. TB–HIV indicator (collaborative sites) and MDR-TB treatment indicators are funded by GFATM and other donors, while the others are funded by GFATM only.

2014

The cumulative results for 2014 are shown as a percentage of the annual target. TB/HIV indicator (collaborative sites) and MDR-TB treatment indicators are funded by “GFATM and other donors” while the others are funded by GFATM only.

2013

The cumulative results for 2013 are shown as a percentage of the annual target. TB/HIV indicator (collaborative sites) is funded by “GFATM and other donors” while the others are funded by GFATM only.

2012

The cumulative results in each period during Year 2 are shown as a percentage of the annual target. Sex Workers, MSM and IDUs reached are funded by the Global Fund only, while the others are funded by "GFATM and other donors"

2011

The cumulative results in each period (P1-P4) are shown against the annual targets in percentages. TB/HIV (TB/HIV Collaborative Sites) indicator is funded by "GFATM and other donors" while the rest are funded by the Global Fund only.

Malaria Programme Achievements

2023

In 2023, PR-UNOPS and its implementing partners continued to work hard to preserve the continuation of interventions amidst the political instability in the country, so that the essential services regarding malaria control and elimination were not interrupted.

2022

In 2022, PR-UNOPS and its implementing partners continued to work hard to preserve the continuation of essential malaria services while undertaking COVID-19 infection control measures so that the interventions were ensured not to be interrupted.

2021

The  results for 2021 are shown as a percentage of the annual target. 

2020

The non-cumulative results for 2020 are shown as a percentage of the annual target. The LLINs (continuous) distributed indicator is funded by GFATM.

In 2020, during the COVID-19 pandemic PR-UNOPS was working closely with the public sector service providers and implementing partners to maintain prevention, care and treatment services while undertaking COVID-19 infection control measures so that the interventions were ensured not to be interrupted.

2019

The non-cumulative results for 2019 are shown as a percentage of the annual target. The LLINs (continuous) distributed indicator is funded by GFATM. 

2018

The non-cumulative results for 2018 are shown as a percentage of the annual target. The LLINs (continous) distributed indicator is funded by GFATM.

The malaria grant has supported the continouous distribution of 775,252 (71% of target) long-lasting insecticidal bed nets (LLINs) in 2018.

2017

The cumulative results for Year 7 (NFM) are shown as a percentage of the annual target. The LLINs (mass) distributed indicator is funded by GFATM only, while the others are funded by GFATM-Multiple Grant. The LLINs (continuous) distributed indicator is funded by GFATM and 3MDG. 

The malaria grant has supported mass distribution of 1,502,666 (100% of target) and continuous distribution of 1,987,865 (102% of target) long-lasting insecticidal bed nets (LLINs) in 2017.

2016

The cumulative results for Year 6 (NFM) are shown as a percentage of the annual target. The LLINs-distributed indicator is funded by GFATM only, while the others are funded by GFATM-Multiple Grant.

The malaria grant has supported distribution of 2,004,944 (102% of target) long-lasting insecticidal bednets (LLINs) in 2016.

2015

The cumulative results for Year 5 (NFM) are shown as a percentage of the annual target. LLINs distributed indicator is funded by GFATM only, LLINs coverage population indicator is funded by GFATM and other donors, while the others are funded by GFATM-Multiple Grant.

2014

The cumulative results for 2014 are shown as a percentage of the annual target. LLINs distributed and ITNs treated indicators are funded by GFATM only, while the others are funded by “GFATM and other donors”.

2013

The cumulative results for 2013 are shown as a percentage of the annual target. LLINs distributed and ITNs treated indicators are funded by GFATM only, while the others are funded by “GFATM and other donors”.

Provision of Long Lasting Insecticidal Nets (LLINs) in high and moderate risk villages continued in 2013, with 487,479 LLINs distributed (120% of target). Mass campaigns for bed net treatment resulted in 1.2 million (101% of target) nets being treated.

2012

The cumulative results in each period are shown against annual target in the percentages. LLINs Distributed and Nets treated are funded by the Global Fund only while the others are funded by GFATM and other donors.

2011

The cumulative results in each period (P1-P4) are shown against annual target in the percentages. LLINs Distributed and Nets treated are funded by the Global Fund only while the others are funded by GFATM and other donors.

Year 1 saw a massive and rapid scale-up of ITNs and LLINs in high and moderate risk villages, Some 454,720 LLINs (94% of target) were distributed in malaria endemic areas and accelerated mass campaigns for bed net treatment resulted in 689,072 (93%) nets treated with KO tablets in high and moderate risk villages.